Verrica Pharmaceuticals Inc. (VRCA)
NASDAQ: VRCA · Real-Time Price · USD
6.42
+0.15 (2.31%)
At close: May 4, 2026, 4:00 PM EDT
6.36
-0.05 (-0.86%)
After-hours: May 4, 2026, 4:10 PM EDT
Verrica Pharmaceuticals Employees
Verrica Pharmaceuticals had 76 employees as of December 31, 2025. The number of employees increased by 5 or 7.04% compared to the previous year.
Employees
76
Change (1Y)
5
Growth (1Y)
7.04%
Revenue / Employee
$468,118
Profits / Employee
-$235,342
Market Cap
109.26M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 76 | 5 | 7.04% |
| Dec 31, 2024 | 71 | -29 | -29.00% |
| Dec 31, 2023 | 100 | 78 | 354.55% |
| Dec 31, 2022 | 22 | -16 | -42.11% |
| Dec 31, 2021 | 38 | 9 | 31.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Seer, Inc. | 124 |
| Cibus | 118 |
| Fractyl Health | 100 |
| Pyxis Oncology | 56 |
| Vivani Medical | 42 |
| Biomea Fusion | 41 |
| Aardvark Therapeutics | 40 |
| Cardiff Oncology | 31 |
VRCA News
- 19 days ago - Verrica Pharmaceuticals Transcript: 25th Annual Needham Virtual Healthcare Conference - Transcripts
- 25 days ago - Verrica Pharmaceuticals Announces Acceptance of Late-Breaking Abstract Highlighting Potential Abscopal Effect of VP-315 for the Treatment of Basal Cell Carcinoma at the Upcoming 2026 Society for Investigative Dermatology Annual Meeting - GlobeNewsWire
- 4 weeks ago - Verrica Pharmaceuticals to Participate in the 25th Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 6 weeks ago - VRCA Investors Have the Opportunity to Join Investigation of Verrica Pharmaceuticals Inc. with the Schall Law Firm - Business Wire
- 6 weeks ago - VRCA Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Verrica Pharmaceuticals Inc. – VRCA - Business Wire
- 6 weeks ago - Verrica Pharmaceuticals Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Verrica Pharmaceuticals Inc. – VRCA - Business Wire
- 7 weeks ago - Verrica Pharmaceuticals Earnings Call Transcript: Q4 2025 - Transcripts
- 7 weeks ago - Verrica Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire